主要教育和工作经历： 09/2015-06/2017 中山大学附属第一医院 肿瘤学 博士 09/2005-06/2008 中山大学肿瘤防治中心 肿瘤学 硕士 09/2000-07/2005 华中科技大学同济医学院临床医学学士 04/2013-03/2015 哈佛医学院 Beth Israel Deaconess Medical Center 博士后 01/2013-至今 中山大学附属第一医院主治医师 07/2011-12/2012 中山大学附属第一医院医师 08/2008-06/2011 中山大学肿瘤防治中心医师 社会兼职：广东省抗癌协会肝癌委员会青年委员会常委 广东省中西医结合学会肿瘤生物治疗委员会委员 广州市抗癌协会肝胆胰委员会委员 论著（部分代表作）： 1. Peng ZW, Chen SL, Wei MC, et al. Sorafenib with or without Transarterial Chemoembolization plus Radiofrequency Ablation for Advanced Recurrent Hepatocellular Carcinoma. Radiology, in press. IF: 7.296 2. Peng ZW, Wei MC, Chen SL, et al. Combined Transcatheter Arterial Chemoembolization and Radiofrequency Ablation versus Hepatectomy for Recurrent Hepatocellular carcinoma after Initial Surgery: A Propensity Score Matching study. Euro Radiol, in press. IF: 3.967 3. Chen SL, PengZW, Xiao H, et al. Combined Radiofrequency Ablation and Ethanol Injection Versus Repeat Hepatectomy for Elderly Patients with Recurrent Hepatocellular Carcinoma after Initial Hepatic Surgery. Int J Hyperthermia. 2017. Co-first author. IF: 3.262 4. Peng ZW, Rothweiler S, Wei GY, et al. The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis. Hepatol commun. 2017;1:957-972. 5. Peng ZW, Ikenaga N, Liu SB, et al. Integrin αvβ6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis. Hepatology; 2016;63:217-32.IF: 13.246 6. Xu L, Peng ZW, Chen MS, et al. Prognostic Nomogram for Patients with Unresectable Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization. J Hepatol 2015;63:122-30 Co-first author. IF: 12.486 7. Peng ZW, Zhang YJ, Chen MS et al. Radiofrequency Ablation with or without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial. J Clin Oncol.2013;31;426-432.IF: 24.008 8. Peng ZW, Zhang YJ, Chen MS et al. Recurrent Hepatocellular Carcinoma Treated with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation versus Radiofrequency Ablation Alone: A Prospective Randomized Trial. Radiology. 2012; 262:689-700. IF: 7.296 9. Peng ZW, Zhang YJ, Lin XJ, et al. Radiofrequency ablation vs. hepatic resection for the treatment of hepatocellular carcinomas smaller than 2 cm: A retrospective comparative study. Radiology. 2012; 262:1022-1033. IF: 7.296 10. Peng ZW, Liu FR, Ye S, et al. Radiofrequency ablation versus open hepatic resection for elderly patients (>65 years) with very early or early hepatocellular carcinoma. Cancer. 2013; 119:3812-3820. Co-corresponding author. IF: 5.997 其他主要工作成绩（比如获奖情况）： 1. 小肝癌综合治疗，广东省科技进步一等奖 2. 小肝癌综合治疗，教育部科技进步二等奖； 3. 小肝癌经皮射频微创治疗的临床研究(2009)，中国抗癌协会科技奖二等奖 4. 2009年度中山大学肿瘤防治中心“邓先生抗癌科学奖”三等奖； 2007年中山大学优秀研究